Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 34392-85-3 | MDL No. : | MFCD09258809 |
Formula : | C6H7ClN2O | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | AOGGRVIJAHZLFK-UHFFFAOYSA-N |
M.W : | 158.59 | Pubchem ID : | 118674 |
Synonyms : |
|
Num. heavy atoms : | 10 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.17 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 40.14 |
TPSA : | 48.14 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.24 cm/s |
Log Po/w (iLOGP) : | 1.75 |
Log Po/w (XLOGP3) : | 1.44 |
Log Po/w (WLOGP) : | 1.33 |
Log Po/w (MLOGP) : | 0.55 |
Log Po/w (SILICOS-IT) : | 1.27 |
Consensus Log Po/w : | 1.27 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.11 |
Solubility : | 1.24 mg/ml ; 0.00779 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.06 |
Solubility : | 1.39 mg/ml ; 0.00878 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -2.4 |
Solubility : | 0.636 mg/ml ; 0.00401 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.92 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
72% | Stage #1: With water; tin(ll) chloride In ethyl acetate at 70℃; for 1 h; Stage #2: With sodium carbonate In water; ethyl acetate at 20℃; |
Tin(ll)chloride dihydrate (6 g, 26.52 mmol) was added to a solution of 2-chloro-6-methoxy- 3-nitropyridine (1 g, 5.30 mmol) in ethyl acetate (15 ml.) and the resultant suspension heated at 70 °C with stirring for 1 h. The reaction mixture was cooled to ambient temperature, the pH adjusted to pH 9-10 by addition of saturated sodium carbonate (aq.) and extracted with ethyl acetate (3 x 5OmL). The combined extracts were dried (MgSO4) and concentrated in vacuo to give the crude product. Purification by chromatography on silica gel with EtOAc:heptane (3:7, v/v) as eluent afforded the product as a pale yellow oil (600 mg, 72 percent). Data for S-amino-σ-chloro-e-methoxypyridine: MS (ESI) m/z: 159 ([M+H]+). |
69% | With hydrogen In ethanol; ethyl acetate at 15 - 25℃; | A solution of 2-chloro-6-methoxy-3-nitropyridine (1.0 g, 5.3 mmol) in EtOH (50 ml)/EtOAc (50 ml) is hydrogenated at RT and 40 psi, in the presence of 10percent Pd-C (0.394 g, 0.37 mmol). The suspension is filtered through cellulose and washed with EtOH. The solution is concentrated under vacuum to give a brown oil 0.58 g (69percent yield) that is used without further purification in the next step. MS (ESI+) for C6H7ClN2O m/z 159.0 (M+H)+. Example 310 (from 2-chloro-6-methoxypyridin-3-amine and 2-isocyanato-5-(trifluoromethyl)-1,3,4-thiadiazole) is prepared by following Method C, making non-critical modifications. The solid is triturated with CH2Cl2 to give a white solid 0.104 g (47percent yield). HRMS (ESI) calcd for C10H7N5O2SClF3+H 354.0039, found 354.0046. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
41% | Stage #1: With hydrogenchloride; sodium nitrite In water at -5℃; for 0.333333 h; Stage #2: With copper(l) chloride In water at -5 - 20℃; for 3.41667 h; Stage #3: With sodium hydroxide In water |
3-Amino-2-chloro-6-methoxypyridine (500 mg, 3.17 mmol) dissolved/suspended in cone. hydrochloric acid (10 ml.) was stirred at -5 °C while a solution of sodium nitrite (1.09 g, 15.82 mmol) in water (5 ml.) was added dropwise over 10 min. The mixture was stirred for a further 10 min before copper chloride (3.13 g, 31.65 mmol) was added portionwise over 5 min. The dark effervescing mixture was stirred at -5 °C for 20 min and then the cooling bath was removed and the mixture stirred at ambient temperature for 3 h. The mixture was diluted with water (100 ml_), basified to pH 10-1 1 by addition of 5N sodium hydroxide (aq.) and extracted with diethyl ether (3 x 5OmL). The combined extracts were washed with brine, dried (MgSO4) and concentrated in vacuo. The crude product was purified by chromatography on silica gel with EtOAc:heptane (1 :9, v/v) as eluent to afford the product as a pale yellow oil (229 mg, 41 percent). Data for 2,3-dichloro-6-methoxypyridine: MS (ESI) m/z: 178 ([M+H]+). |
41% | Stage #1: With hydrogenchloride; sodium nitrite In water at -5℃; for 0.333333 h; Stage #2: With copper(l) chloride In water at -5 - 20℃; for 3.41667 h; Stage #3: With sodium hydroxide In waterAlkaline aqueous solution |
3-Amino-2-chloro-6-methoxypyridine (500 mg, 3.17 mmol) dissolved/suspended in conc. hydrochloric acid (10 mL) was stirred at -5 C. while a solution of sodium nitrite (1.09 g, 15.82 mmol) in water (5 mL) was added dropwise over 10 min. The mixture was stirred for a further 10 min before copper chloride (3.13 g, 31.65 mmol) was added portionwise over 5 min. The dark effervescing mixture was stirred at -5 C. for 20 min and then the cooling bath was removed and the mixture stirred at ambient temperature for 3 h. The mixture was diluted with water (100 mL), basified to pH 10-11 by addition of 5N sodium hydroxide (aq.) and extracted with diethyl ether (3 50 mL). The combined extracts were washed with brine, dried (MgSO4) and concentrated in vacuo. The crude product was purified by chromatography on silica gel with EtOAc:heptane (1:9, v/v) as eluent to afford the product as a pale yellow oil (229 mg, 41percent).Data for 2,3-dichloro-6-methoxypyridine: MS (ESI) m/z: 178 ([M+H]+). |
[ 1008304-85-5 ]
2-Chloro-6-methoxypyridin-4-amine
Similarity: 0.84
[ 25297-52-3 ]
2-Chloro-6-methoxy-4-methylpyridine
Similarity: 0.81
[ 38533-61-8 ]
2-Chloro-6-methoxy-3-nitropyridine
Similarity: 0.81
[ 108279-89-6 ]
2-Chloro-4,6-dimethoxypyridine
Similarity: 0.76
[ 1227572-43-1 ]
2,4-Dichloro-6-methoxypyridine
Similarity: 0.76
[ 1008304-85-5 ]
2-Chloro-6-methoxypyridin-4-amine
Similarity: 0.84
[ 25297-52-3 ]
2-Chloro-6-methoxy-4-methylpyridine
Similarity: 0.81
[ 38533-61-8 ]
2-Chloro-6-methoxy-3-nitropyridine
Similarity: 0.81
[ 108279-89-6 ]
2-Chloro-4,6-dimethoxypyridine
Similarity: 0.76
[ 1227572-43-1 ]
2,4-Dichloro-6-methoxypyridine
Similarity: 0.76
[ 1008304-85-5 ]
2-Chloro-6-methoxypyridin-4-amine
Similarity: 0.84
[ 158387-20-3 ]
5-Chloro-6-methoxypyridin-3-amine
Similarity: 0.72
[ 720666-45-5 ]
2-Chloro-5-methoxypyridin-3-amine
Similarity: 0.71
[ 1008304-85-5 ]
2-Chloro-6-methoxypyridin-4-amine
Similarity: 0.84
[ 25297-52-3 ]
2-Chloro-6-methoxy-4-methylpyridine
Similarity: 0.81
[ 38533-61-8 ]
2-Chloro-6-methoxy-3-nitropyridine
Similarity: 0.81
[ 108279-89-6 ]
2-Chloro-4,6-dimethoxypyridine
Similarity: 0.76
[ 1227572-43-1 ]
2,4-Dichloro-6-methoxypyridine
Similarity: 0.76